Kazmira Revenue and Competitors

Watkins, CO USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kazmira's estimated annual revenue is currently $4.2M per year.(i)
  • Kazmira's estimated revenue per employee is $155,000

Employee Data

  • Kazmira has 27 Employees.(i)
  • Kazmira grew their employee count by 4% last year.

Kazmira's People

NameTitleEmail/Phone
1
Co-founder, CEOReveal Email/Phone
2
co-Founder, co-CEOReveal Email/Phone
3
Manufacturing Engineer llReveal Email/Phone
4
Marketing Coordinator LeadReveal Email/Phone
5
Process Control EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M110%N/AN/A
#2
$2.8M1813%N/AN/A
#3
$70.2M453-1%N/AN/A
#4
$1.6M10-66%N/AN/A
#5
$3.7M24-8%N/AN/A
#6
$2.9M3728%N/AN/A
#7
$3.1M2025%N/AN/A
#8
$2.5M16-20%N/AN/A
#9
$9.1M590%N/AN/A
#10
$4.2M27-7%N/AN/A
Add Company

What Is Kazmira?

Kazmira - The Cannabinoid Company. Committed to enabling greater access to Industrial Hemp derived cannabinoids through deep science, policy and education. We have an experienced team of scientists and engineers who specialize in extraction, purification, and formulation of professional cannabinoid products at our 200,000 sq. ft. facility in Watkins, Colorado. ISO 9001 Certified, cGMP Compliant, Licensed by CDPHE, Kosher Certified Imperial Oil: our premier product, a high potency CBD oil free from THC, diluents, fillers and artificial ingredients. We offer premium, wholesale cannabinoid extracts and a Private Label program with a diverse product portfolio. Our omni-channel brand, Dr. Diol, offers a direct to consumer retail option with our highest quality products. Zero THC, simple ingredients, and unparalleled reliability. What’s Inside Matters. All of our products are thoroughly tested by third-party laboratories to ensure safety and transparency. We are committed to leading the industry in quality standards. info@kazmira-llc.com

keywords:N/A

N/A

Total Funding

27

Number of Employees

$4.2M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator